Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

REMS Communications Need FDA Logo To Boost Doctors’ Attention, Advisors Say

Executive Summary

Risk Communication Advisory Committee suggests that adding the agency imprimatur to REMS materials may help distinguish it from promotional mail and ensure providers read the communications.

You may also be interested in...



Chantix's Boxed Warning: Will A Positive Vote Justify A Negative Outcome?

FDA could use advisory committee members' comments to maintain the smoking cessation drug's boxed warning, even though they voted to remove it.

FDA Logo Modernization Aims For Uniform 'Look And Feel'

Changes will eliminate more distinctive graphics for individual centers to help make agency communications more consistent.

REMS Standardization Could Help Opioid Education Efforts

FDA hopes to begin accepting Risk Evaluation and Mitigation Strategy documents in structured product labeling format later this year.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS055825

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel